Iveric Bio Inc (ISEE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -59,115 | -33,665 | -15,076 | -58,859 | -41,381 |
| Depreciation Amortization | 223 | 77 | 38 | 162 | 123 |
| Accounts payable and accrued liabilities | 1,383 | -995 | -3,254 | -241 | -2,203 |
| Other Working Capital | 7,820 | -879 | -4,812 | 1,092 | -1,976 |
| Other Operating Activity | 4,661 | 5,192 | 5,578 | 9,356 | 8,856 |
| Operating Cash Flow | $-45,028 | $-30,270 | $-17,526 | $-48,490 | $-36,581 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | 150 | 150 |
| Purchase Of Investment | -108,305 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-108,305 | $N/A | $N/A | $150 | $150 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 117,216 | 117,069 | 179 | 42,838 | 81 |
| Other Financing Activity | 33,237 | 33,237 | 0 | 0 | 0 |
| Financing Cash Flow | $150,453 | $150,306 | $179 | $42,838 | $81 |
| Beginning Cash Position | 125,699 | 125,699 | 125,699 | 131,201 | 131,201 |
| End Cash Position | 122,819 | 245,735 | 108,352 | 125,699 | 94,851 |
| Net Cash Flow | $-2,880 | $120,036 | $-17,347 | $-5,502 | $-36,350 |
| Free Cash Flow | |||||
| Operating Cash Flow | -45,028 | -30,270 | -17,526 | -48,490 | -36,581 |
| Free Cash Flow | -45,028 | -30,270 | -17,526 | -48,490 | -36,581 |